The Neuroendocrine Tumor Research Foundation (NETRF) is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) to improve and extend the lives of those living with NETs.
Oncologist Mark Lewis, MD, discusses what we have learned about COVID-19 and NETs in the first six months of the pandemic in this video interview with NETRF CEO Elyse Gellerman.
NETRF is shining a light on its Everlasting Impact Tribute program, which helps families make a larger impact on NET research with a dynamic program that honors their loved ones.
Beginning in August, the NETWise podcast is putting together primary site-specific episodes. NETs can arise almost anywhere in the body, but most start in the gastrointestinal tract, lung, and pancreas.
Check out some of the things we are planning for our October 10th virtual conference for patients and families. We guarantee it’s not your average NET conference. Because you set the agenda!
Brian Bowe has weathered many storms: changes in his career, his marriage, and a tragic mass shooting. Looking back, he says one step helped him most in his recovery from neuroendocrine cancer: attending a support group.
Annual USA Giving report shows robust philanthropic activity in 2019, paving the way to a strong start for nonprofit giving in 2020.
Early NETRF-funded research identifies a potential prognostic biomarker to help physicians predict neuroendocrine cancer outcomes.
Felicia Temple, a rising R&B star living with NETs trades in sequins for scrubs to work as a nurse in a COVID-19 ICU.
COVID economic stimulus regulations offer tax advantages for charitable donations. See how you can take advantage of the opportunity.
NETRF Annual Report 2019 looks at scientific milestones and educational innovations. It includes stories about some of the people who have supported us to fund more research projects than ever before and offer new ways to learn about NETs.